Published on
Emergency and Acute Medicine - Tetanus


Tetanus is a life-threatening neurologic disease caused by a toxin-producing bacterium and is now rare in developed countries but remains common worldwide, particularly in regions with limited vaccination coverage. Although only a small number of cases occur annually in countries like the United States, the disease still carries a high mortality rate. Most cases occur in individuals who are unvaccinated, inadequately immunized, or have not received a booster within the past 10 years. The incubation period typically ranges from 48 hours to several weeks, and a shorter onset period is associated with a worse prognosis. Neonatal tetanus, often resulting from infection of the umbilical stump, remains a major cause of infant mortality in developing regions.


The disease is caused by Clostridium tetani, an anaerobic, spore-forming gram-positive bacterium found in soil and animal feces. Its spores are highly resistant and can survive in harsh environments for long periods. Infection occurs when spores enter a wound or devitalized tissue and germinate under anaerobic conditions. The organism produces tetanospasmin, a potent neurotoxin that interferes with inhibitory neurotransmitters such as GABA, leading to uncontrolled muscle contractions, rigidity, and autonomic dysfunction.


Clinically, tetanus most commonly presents as a generalized form, characterized initially by muscle stiffness and pain, especially involving the jaw (trismus). This progresses to the classic facial expression known as risus sardonicus and generalized muscle rigidity. Patients may develop severe muscle spasms, including opisthotonos (arching of the back), limb rigidity, and clenched fists. Respiratory compromise can occur due to diaphragmatic involvement. Autonomic instability, including fluctuations in blood pressure, arrhythmias, and hyperthermia, is a major cause of death and often develops later in the course.


Other forms include localized tetanus, which causes muscle spasms near the site of injury and may persist for months, and cephalic tetanus, which follows head injuries or ear infections and involves cranial nerve dysfunction. Neonatal tetanus presents in the first weeks of life with poor feeding, irritability, and generalized spasms, and carries an extremely high mortality rate.


Diagnosis is primarily clinical, based on characteristic signs such as trismus and muscle rigidity. Laboratory tests are not diagnostic but may help exclude other conditions or assess complications. Wound cultures for the organism are often negative, and cerebrospinal fluid is typically normal. Differential diagnoses include conditions such as strychnine poisoning, meningitis, encephalitis, dystonic drug reactions, and other causes of muscle rigidity or spasms.


Management requires urgent supportive care and focuses on three main goals: stabilization, neutralization of toxin, and eradication of the organism. Airway management is critical, and early intubation is often necessary due to the risk of respiratory compromise. Muscle spasms are treated with benzodiazepines, and severe cases may require additional agents such as dantrolene or neuromuscular blockade. Autonomic instability is difficult to manage and may require medications such as labetalol, magnesium, or sedatives.


Neutralization of unbound toxin is achieved with tetanus immune globulin, which should be administered as early as possible. However, it does not affect toxin already bound to the nervous system. Elimination of the bacteria is accomplished through wound debridement and antibiotic therapy, with metronidazole being the preferred agent.


Prevention is essential and relies on vaccination. Routine immunization begins in childhood, with booster doses recommended every 10 years. In the setting of wounds, vaccination status must be assessed, and tetanus prophylaxis provided as indicated. Importantly, natural infection does not confer immunity, so patients must still be vaccinated after recovery.


All patients with suspected generalized tetanus require admission to an intensive care unit due to the risk of rapid deterioration and life-threatening complications. Early recognition, aggressive supportive care, and timely administration of immune globulin and antibiotics are critical in improving outcomes.

​
Picture
0 Comments